http://rdf.ncbi.nlm.nih.gov/pubchem/reference/24101659

Outgoing Links

Predicate Object
contentType English Abstract|Guideline|Journal Article|Review
endingPage 95
issn 0720-4299
issueIdentifier 12
pageRange 679-95
publicationName Fortschritte der Neurologie-Psychiatrie
startingPage 679
bibliographicCitation Thomasius R, Gouzoulis-Mayfrank E, Karus C, Wiedenmann H, Hermle L, Sack PM, Zeichner D, Küstner U, Schindler A, Krüger A, Uhlmann S, Petersen KU, Zapletalova P, Wartberg L, Schütz CG, Schulte-Markwort M, Obrocki J, Heinz A, Schmoldt A; Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaft. [AWMF-guideline: cocaine-, amphetamine-, ecstasy- and hallucinogen-related disorders]. Fortschr Neurol Psychiatr. 2004 Dec;72(12):679–95. doi: 10.1055/s-2004-818531. PMID: 15580533.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ef2787d3534d4ae3b94067f223d8cbd6
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2ab58e54a2bb346aef3a63a8e651e062
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f2d23cb2127f2b807e3ca8962d1b2e06
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c0223609922e38b160a0cf246233206e
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b954787e4e32760dd9e44e4ee79ede72
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0c2a01fc426db51094535b27e3cb04b9
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f1e1d1ce1f2d1f38e64f2277df4a09f1
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_36af7ce6ea20255d5b1a44ae455f56bd
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8f0e81b8c94d51675e8f45ef28e9d3e2
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6c07947f54187e14d67bb72acd9c5dce
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2856e6a9daf3ed7c49ca0527cd391e30
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d78121ce43a5e702c714d2bd25c45b86
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5898f6eb9f941d89f4b7a1668d698199
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8e5dd7eaf4ea23ce40902a23dc2812cf
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6af0360ea82dab1b04d507a76c92c78c
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_483ccd34c833c38c83e23e1476e9c71f
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ef249f0e75c0d9a2b4729cb8ddb7cdf0
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3d7b433fad8235564684d8d30fe8c983
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e47addc1729325ad6b83cee280e3c9fc
date 200412
identifier https://doi.org/10.1055/s-2004-818531
https://pubmed.ncbi.nlm.nih.gov/15580533
isPartOf http://rdf.ncbi.nlm.nih.gov/pubchem/journal/3772
https://portal.issn.org/resource/ISSN/0720-4299
language German
source https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/
title [AWMF-guideline: cocaine-, amphetamine-, ecstasy- and hallucinogen-related disorders]
discusses http://id.nlm.nih.gov/mesh/M0009763
http://id.nlm.nih.gov/mesh/M0028171
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D006213
http://id.nlm.nih.gov/mesh/D019966Q000628
http://id.nlm.nih.gov/mesh/D019969Q000628
http://id.nlm.nih.gov/mesh/D019970Q000628
http://id.nlm.nih.gov/mesh/D018817
hasSubjectTerm http://id.nlm.nih.gov/mesh/D005260
http://id.nlm.nih.gov/mesh/D019317
http://id.nlm.nih.gov/mesh/D011247
http://id.nlm.nih.gov/mesh/D000328
http://id.nlm.nih.gov/mesh/D015897
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D019966Q000503
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID446220
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3007
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1615
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10420

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128445969
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129238625
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129937523

Total number of triples: 57.